Precigen, Inc. (PGEN) key performance indicators and operating metrics (12 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| PAPZIMEOS patient hub enrollment | 500.00 | FY2026-Q2 |
| PAPZIMEOS United States insured lives coverage | 90.00 percent | FY2026-Q1 |
| PAPZIMEOS net product revenue | 53.07M | FY2026-Q2 |
| PAPZIMEOS target medical institutions engaged | 100.00 percent | FY2026-Q2 |
| Complete response rate | 51.00 percent | FY2025-Q1 |
| Decrease in surgical interventions | 86.00 percent | FY2025-Q1 |
| PAPZIMEOS accessible lives | 315M | FY2026-Q2 |
| Private health insurance coverage | 215M | FY2026-Q1 |
| United States adult recurrent respiratory papillomatosis patients | 27K | FY2025-Q3 |
| Cash burn | -16.9M | FY2025-Q1 |
| Exemplar revenue | 192K | FY2026-Q2 |
| Non Us · Product revenue | 165K | FY2026-Q2 |
Back to PGEN overview · PGEN earnings · PGEN holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.